Endocrine Society to host virtual Science Writers Conference Nov. 14
Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.
Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14.
What: The Virtual Science Writers Conference will examine:
Who:
When: Thursday, Nov. 14 at 10 AM Eastern
Register to attend the virtual Science Writers Conference by emailing media@endocrine.org. Registered reporters will receive log-in details.
Priority will be given to journalists seeking to register. The recording of this event will be made available on the Society’s YouTube channel for other audiences.
Eli Lilly provided support for this event.
About Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.
Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 cwilliams@endocrine.org
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 jgingery@endocrine.org
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.